Vitamin D and obesity: Current perspectives and future directions

Proceedings of the Nutrition Society

Volumn 74, Issue 2, 2015, Pages 115-124

  Pourshahidi, L Kirsty ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Adipose tissue; BMI; Fat mass; Obesity; Vitamin D

Indexed keywords

VITAMIN D;

ANIMAL; BODY MASS; DIET THERAPY; DIETARY REFERENCE INTAKE; DIETARY SUPPLEMENT; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOLOGY; METABOLISM; NUTRITIONAL STATUS; OBESITY; ORGANIZATION; OVERWEIGHT; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; VITAMIN D DEFICIENCY;

ADIPOSITY; ANIMALS; BODY MASS INDEX; CONGRESSES AS TOPIC; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HUMANS; NUTRITIONAL STATUS; OBESITY; OVERWEIGHT; PRECISION MEDICINE; RECOMMENDED DIETARY ALLOWANCES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84928882385     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665114001578     Document Type: Conference Paper

References (110)

1. Suda T, Ueno Y, Fujii K et al. (2003) Vitamin D and bone. J Cell Biochem 88, 259-266.
2. Holick MF (2008) Deficiency of sunlight and vitamin D. BMJ 336, 1318-1319.
3. Kaidar-Person O, Person B, Szomstein S et al. (2008) Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part A: vitamins. Obes Surg 18, 870-876.
4. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357, 266-281.
5. Schottker B, Haug U, Schomburg L et al. (2013) Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr 97, 782-793.
6. MacLaughlin JA, Anderson RR & Holick MF (1982) Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 216, 1001-1003.
7. Webb AR & Holick MF (1988) The role of sunlight in the cutaneous production of vitamin D3. Annu Rev Nutr 8, 375-399.
8. Rosenstreich SJ, Rich C & Volwiler W (1971) Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. J Clin Invest 50, 679-687.
9. Mawer EB, Backhouse J, Holman CA et al. (1972) The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 43, 413-431.
10. Jablonski NG & Chaplin G (2000) The evolution of human skin coloration. J Hum Evol 39, 57-106.
11. Yuen AW & Jablonski NG (2010) Vitamin D: in the evolution of human skin colour. Med Hypotheses 74, 39-44.
12. Kuan V, Martineau AR, Griffiths CJ et al. (2013) DHCR7 mutations linked to higher vitamin D status allowed early human migration to northern latitudes. BMC Evol Biol 13, 144.
13. Chaplin G & Jablonski NG (2013) The human environment and the vitamin d compromise: Scotland as a case study in human biocultural adaptation and disease susceptibility. Hum Biol 85, 529-552.
14. Verbraecken J, Van de Heyning P, De Backer W et al. (2006) Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism 55, 515-524.
15. Compston JE, Vedi S, Ledger JE et al. (1981) Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34, 2359-2363.
16. Looker AC (2007) Do body fat and exercise modulate vitamin D status? Nutr Rev 65, S124-S126.
17. Vanlint S (2013) Vitamin D and obesity. Nutrients 5, 949-956.
18. Petersen L, Schnohr P & Sorensen TI (2004) Longitudinal study of the long-term relation between physical activity and obesity in adults. Int J Obes Relat Metab Disord 28, 105-112.
19. Atienza AA, Yaroch AL, Masse LC et al. (2006) Identifying sedentary subgroups: the National Cancer Institutes Health Information National Trends Survey. Am J Prev Med 31, 383-390.
20. Hey H, Stokholm KH, Lund B et al. (1982) Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes 6, 473-479.
21. Bell NH, Epstein S, Greene A et al. (1985) Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76, 370-373.
22. Parikh SJ, Edelman M, Uwaifo GI et al. (2004) The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89, 1196-1199.
23. Konradsen S, Ag H, Lindberg F et al. (2008) Serum 1, 25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 47, 87-91.
24. Moan J, Lagunova Z, Lindberg FA et al. (2009) Seasonal variation of 1, 25-dihydroxyvitamin D and its association with body mass index and age. J Steroid Biochem Mol Biol 113, 217-221.
25. Lagunova Z, Porojnicu AC, Vieth R et al. (2011) Serum 25-hydroxyvitamin D is a predictor of serum 1, 25-dihydroxyvitamin D in overweight and obese patients. J Nutr 141, 112-117.
26. Wortsman J, Matsuoka LY, Chen TC et al. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690-693.
27. Hossein-nezhad A & Holick MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88, 720-755.
28. Lawson DE, Douglas J, Lean M et al. (1986) Estimation of vitamin D3 and 25-hydroxyvitamin D3 in muscle and adipose tissue of rats and man. Clin Chim Acta 157, 175-181.
29. Blum M, Dolnikowski G, Seyoum E et al. (2008) Vitamin D(3) in fat tissue. Endocrine 33, 90-94.
30. Malmberg P, Karlsson T, Svensson H et al. (2014) A new approach to measuring vitamin D in human adipose tissue using time-of-flight secondary ion mass spectrometry: a pilot study. J Photochem Photobiol B 138, 295-301.
31. Drincic AT, Armas LA, Van Diest EE et al. (2012) Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 20, 1444-1448.
32. Institute of Medicine (IOM). (2011) Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press.
33. Teitelbaum SL, Halverson JD, Bates M et al. (1977) Abnormalities of circulating 25-OH vitamin D after jejunal-lleal bypass for obesity: evidence of an adaptive response. Ann Intern Med 86, 289-293.
34. Rickers H, Christiansen C, Balslev I et al. (1984) Impairment of vitamin D metabolism and bone mineral content after intestinal bypass for obesity. A longitudinal study. Scand J Gastroenterol 19, 184-189.
35. Liel Y, Ulmer E, Shary J et al. (1988) Low circulating vitamin D in obesity. Calcif Tissue Int 43, 199-201.
36. Buffington C, Walker B, Cowan GS Jr et al. (1993) Vitamin D deficiency in the morbidly obese. Obes Surg 3, 421-424.
37. Stein J, Stier C, Raab H et al. (2014) Review article: the nutritional and pharmacological consequences of obesity surgery. Aliment Pharmacol Ther 40, 582-609.
38. Flores L, Moize V, Ortega E et al. (2014) Prospective study of individualized or high fixed doses of vitamin D supplementation after bariatric surgery. Obes Surg (Epublication ahead of print).
39. Cashman KD, Hill TR, Lucey AJ et al. (2008) Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 88, 1535-1542.
40. Cashman KD, Wallace JM, Horigan G et al. (2009) Estimation of the dietary requirement for vitamin D in freeliving adults =64 y of age. Am J Clin Nutr 89, 1366-1374.
41. Forsythe LK, Livingstone MB, Barnes MS et al. (2012) Effect of adiposity on vitamin D status and the 25-hydroxycholecalciferol response to supplementation in healthy young and older Irish adults. Br J Nutr 107, 126-134.
42. Hypponen E & Power C (2006) Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diab Care 29, 2244-2246.
43. Samuel L & Borrell LN (2013) The effect of body mass index on optimal vitamin D status in U.S. adults: the National Health and Nutrition Examination Survey 2001-2006. Ann Epidemiol 23, 409-414.
44. Foss YJ (2009) Vitamin D deficiency is the cause of common obesity. Med Hypotheses 72, 314-321.
45. Saneei P, Salehi-Abargouei A & Esmaillzadeh A (2013) Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev 14, 393-404.
46. Vimaleswaran KS, Berry DJ, Lu C et al. (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10, e1001383.
47. Vimaleswaran KS, Cavadino A, Berry DJ et al. (2013) Genetic association analysis of vitamin D pathway with obesity traits. Int J Obes (Lond) 37, 1399-1406.
48. Ding C, Gao D, Wilding J et al. (2012) Vitamin D signalling in adipose tissue. Br J Nutr 108, 1915-1923.
49. Mutt SJ, Hypponen E, Saarnio J et al. (2014) Vitamin D and adipose tissue-more than storage. Front Physiol 5, 228.
50. Narvaez CJ, Matthews D, Broun E et al. (2009) Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 150, 651-661.
51. Soares MJ, Chan She Ping-Delfos W & Ghanbari MH (2011) Calcium and vitamin D for obesity: a review of randomized controlled trials. Eur J Clin Nutr 65, 994-1004.
52. Nimitphong H, Holick MF, Fried SK et al. (2012) 25-hydroxyvitamin D(3) and 1, 25-dihydroxyvitamin D(3) promote the differentiation of human subcutaneous preadipocytes. PLoS ONE 7, e52171.
53. Caron-Jobin M, Morisset AS, Tremblay A et al. (2011) Elevated serum 25(OH)D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity (Silver Spring) 19, 1335-1341.
54. Marcotorchino J, Tourniaire F, Astier J et al. (2014) Vitamin D protects against diet-induced obesity by enhancing fatty acid oxidation. J Nutr Biochem 25, 1077-1083.
55. Sergeev IN & Song Q (2014) High vitamin D and calcium intakes reduce diet-induced obesity in mice by increasing adipose tissue apoptosis. Mol Nutr Food Res 58, 1342-1348.
56. Caan B, Neuhouser M, Aragaki A et al. (2007) Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med 167, 893-902.
57. Rock CL, Emond JA, Flatt SW et al. (2012) Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity (Silver Spring) 20, 2296-2301.
58. Jamal-Allial A, Griffith JL & Tucker KL (2013) The longitudinal association of vitamin D serum concentrations & adiposity phenotype. J Steroid Biochem Mol Biol 144, 185-188.
59. Tzotzas T, Papadopoulou FG, Tziomalos K et al. (2010) Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 95, 4251-4257.
60. Mason C, Xiao L, Imayama I et al. (2011) Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 94, 95-103.
61. Sneve M, Figenschau Y & Jorde R (2008) Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 159, 675-684.
62. Zittermann A, Frisch S, Berthold HK et al. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321-1327.
63. Zhu W, Cai D, Wang Y et al. (2013) Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with very-low calcium consumption: a randomized controlled trial. Nutr J 12, 8.
64. Mason C, Xiao L, Imayama I et al. (2014) Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr 99, 1015-1025.
65. Pathak K, Soares MJ, Calton EK et al. (2014) Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 15, 528-537.
66. Soares MJ, Murhadi LL, Kurpad AV et al. (2012) Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes Rev 13, 592-605.
67. Ryynanen J, Neme A, Tuomainen TP et al. (2014) Changes in vitamin D target gene expression in adipose tissue monitor the vitamin D response of human individuals. Mol Nutr Food Res 58, 2036-2045.
68. Zhang Y, Proenca R, Maffei M et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.
69. Mohamed-Ali V, Pinkney JH & Coppack SW (1998) Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22, 1145-1158.
70. Ahima RS & Flier JS (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11, 327-332.
71. Hotamisligil GS, Arner P, Caro JF et al. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95, 2409-2415.
72. Scherer PE, Williams S, Fogliano M et al. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270, 26746-26749.
73. Arita Y, Kihara S, Ouchi N et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79-83.
74. Yudkin JS, Stehouwer CD, Emeis JJ et al. (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19, 972-978.
75. Weisberg SP, McCann D, Desai M et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
76. Xu H, Barnes GT, Yang Q et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830.
77. Frayn KN (2005) Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 64, 7-13.
78. Fain JN (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74, 443-477.
79. Trayhurn P & Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347-355.
80. Greenberg AS & Obin MS (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83, 461S-465S.
81. Ronti T, Lupattelli G & Mannarino E (2006) The endocrine function of adipose tissue: an update. Clin Endocrinol 64, 355-365.
82. Tilg H & Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6, 772-783.
83. Galic S, Oakhill JS & Steinberg GR (2010) Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316, 129-139.
84. Dietrich M & Jialal I (2005) The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. Nutr Rev 63, 22-28.
85. Devaraj S, Kasim-Karakas S & Jialal I (2006) The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep 8, 477-486.
86. Selvin E, Paynter NP & Erlinger TP (2007) The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167, 31-39.
87. Forsythe LK, Wallace JM & Livingstone MB (2008) Obesity and inflammation: the effects of weight loss. Nutr Res Rev 21, 117-133.
88. Louw JA, Werbeck A, Louw ME et al. (1992) Blood vitamin concentrations during the acute-phase response. Crit Care Med 20, 934-941.
89. Waldron JL, Ashby HL, Cornes MP et al. (2013) Vitamin D: a negative acute phase reactant. J Clin Pathol 66, 620-622.
90. Al-Daghri NM, Guerini FR, Al-Attas OS et al. (2014) Vitamin d receptor gene polymorphisms are associated with obesity and inflammosome activity. PLoS ONE 9, e102141.
91. Edita S, Aleksandar K, Dragana TN et al. (2014) Vitamin D and Dysfunctional Adipose Tissue in Obesity. Angiology (Epublication ahead of print).
92. Ghashut RA, Talwar D, Kinsella J et al. (2014) The effect of the systemic inflammatory response on plasma vitamin 25 (OH) D concentrations adjusted for albumin. PLoS ONE 9, e92614.
93. Karelis AD (2008) Metabolically healthy but obese individuals. Lancet 372, 1281-1283.
94. Karelis AD & Rabasa-Lhoret R (2008) Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diab Metab 34, 183-184.
95. Primeau V, Coderre L, Karelis AD et al. (2011) Characterizing the profile of obese patients who are metabolically healthy. Int J Obes 35, 971-981.
96. Karelis AD & Rabasa-Lhoret R (2014) Characterization of metabolically healthy but obese individuals: Should we add vitamin D to the puzzle? Diab Metab (Epublication ahead of print).
97. Esteghamati A, Aryan Z, Esteghamati A et al. (2014) Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects. Diab Metab (Epublication ahead of print).
98. Brannon PM, Yetley EA, Bailey RL et al. (2008) Overview of the conference Vitamin D and Health in the 21st Century: an Update. Am J Clin Nutr 88, 483S-490S.
99. Barger-Lux MJ, Heaney RP, Dowell S et al. (1998) Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 8, 222-230.
100. Canto-Costa MH, Kunii I & Hauache OM (2006) Body fat and cholecalciferol supplementation in elderly homebound individuals. Braz J Med Biol Res 39, 91-98.
101. Blum M, Dallal GE & Dawson-Hughes B (2008) Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr 27, 274-279.
102. NelsonML, BlumJM, HollisBWet al. (2009) Supplements of 20 microg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80 % of premenopausal women in winter. J Nutr 139, 540-546.
103. Lee P, Greenfield JR, Seibel MJ et al. (2009) Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med 122, 1056-1060.
104. Drincic A, Fuller E, Heaney RP et al. (2013) 25-Hydroxyvitamin D response to graded vitamin D(3) supplementation among obese adults. J Clin Endocrinol Metab 98, 4845-4851.
105. Gallagher JC, Yalamanchili V & Smith LM (2013) The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J Steroid Biochem Mol Biol 136, 195-200.
106. Waterhouse M, Tran B, Armstrong BK et al. (2014) Environmental, personal, and genetic determinants of response to vitamin d supplementation in older adults. J Clin Endocrinol Metab 99, E1332-E1340.
107. Bryant GA, Koenigsfeld CF, Lehman NP et al. (2014) A retrospective evaluation of response to vitamin D supplementation in obese versus nonobese patients. J Pharm Pract (Epublication ahead of print).
108. Zittermann A, Ernst JB, Gummert JF et al. (2014) Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr 53, 367-374.
109. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96, 1911-1930.
110. Dhaliwal R, Mikhail M, Feuerman M et al. (2014) The vitamin D dose response in obesity. Endocr Pract 1-25.